Literature DB >> 10497080

Plasma fibronectin: three steps to purification and stability.

L Poulouin1, O Gallet, M Rouahi, J M Imhoff.   

Abstract

Large amounts of soluble fibronectin were easily purified from cryoprecipitated or fresh citrated human blood plasma by a three-step combination of gelatin and heparin-cellufine affinity chromatography. The elution conditions were optimized to obtain a homogeneous fraction on SDS-PAGE and Western blot under reducing condition. No proteolytic activities were detected by zymography at acidic or neutral pH. Furthermore, the fibronectin preparation was stable over time up to 456 h at 37 degrees C in the presence of calcium, zinc, or mercury. This preparation of very stable fibronectin, called highly purified fibronectin (hpFN), gave a yield of 7.00 +/- 0.77 mg of fibronectin per gram of cryoprecipitated plasma and 0.16 mg of fibronectin per milliliter of fresh citrated, giving a yield of 32 to 53% (from presumed fibronectin concentration). This preparation may be useful for cellular tests and interaction analysis. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497080     DOI: 10.1006/prep.1999.1103

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  11 in total

1.  Refolding of a high molecular weight protein: salt effect on collapse.

Authors:  D Lairez; E Pauthe; J Pelta
Journal:  Biophys J       Date:  2003-06       Impact factor: 4.033

2.  Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin.

Authors:  Sabrina Kellouche; Julien Fernandes; Johanne Leroy-Dudal; Olivier Gallet; Soizic Dutoit; Laurent Poulain; Franck Carreiras
Journal:  Tumour Biol       Date:  2010-02-24

3.  Fabrication of functional fibronectin patterns by nanosecond excimer laser direct write for tissue engineering applications.

Authors:  S Grigorescu; M Hindié; E Axente; F Carreiras; K Anselme; J Werckmann; I N Mihailescu; O Gallet
Journal:  J Mater Sci Mater Med       Date:  2013-04-25       Impact factor: 3.896

4.  alpha5beta1 integrins and fibronectin are involved in adherence of the Pseudomonas aeruginosa ER97314 clinical strain to A549 cells.

Authors:  H Gagnière; P Di Martino
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

5.  New synthesis method of HA/P(D,L)LA composites: study of fibronectin adsorption and their effects in osteoblastic behavior for bone tissue engineering.

Authors:  Sabeha Yala; Mahfoud Boustta; Olivier Gallet; Mathilde Hindié; Franck Carreiras; Hamanou Benachour; Djahida Sidane; Hafit Khireddine
Journal:  J Mater Sci Mater Med       Date:  2016-08-17       Impact factor: 3.896

6.  Co-purified gelatinases alter the stability and biological activities of human plasma fibronectin preparations.

Authors:  S Pal; Z Chen; X Xu; M Mikhailova; B Steffensen
Journal:  J Periodontal Res       Date:  2009-11-09       Impact factor: 4.419

7.  Direct spatial control of Epac1 by cyclic AMP.

Authors:  Bas Ponsioen; Martijn Gloerich; Laila Ritsma; Holger Rehmann; Johannes L Bos; Kees Jalink
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

8.  On the potential for fibronectin/phosphorylcholine coatings on PTFE substrates to jointly modulate endothelial cell adhesion and hemocompatibility properties.

Authors:  Vanessa Montaño-Machado; Pascale Chevallier; Diego Mantovani; Emmanuel Pauthe
Journal:  Biomatter       Date:  2015

9.  Rap1 can bypass the FAK-Src-Paxillin cascade to induce cell spreading and focal adhesion formation.

Authors:  Sarah H Ross; Emma Spanjaard; Anneke Post; Marjolein J Vliem; Hendy Kristyanto; Johannes L Bos; Johan de Rooij
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

10.  Characterization of the bacteriophages binding to human matrix molecules.

Authors:  Chandni Porayath; Amrita Salim; Archana Palillam Veedu; Pradeesh Babu; Bipin Nair; Ajith Madhavan; Sanjay Pal
Journal:  Int J Biol Macromol       Date:  2017-12-12       Impact factor: 6.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.